“Traditionally, when you talk to people who have Parkinson's or Alzheimer's, they'll talk about how they're in five or six studies, and they've been sequenced by each study. That's just fat in the system. Just have a single data set that then you can share. You can make the entire system more efficient.”

Anne Wojcicki is a Silicon Valley entrepreneur and philanthropist. She co-founded 23andMe, a company pioneering genetic testing and personalized health data, and later launched Verily, a life sciences research arm of Alphabet. Her work centers on merging technology with medicine to advance preventive healthcare and genetic research.